Do the levels of tumor makers or proinflammatory cytokines in mid-trimester cervical fluid predict early-stage cervical shortening?

Journal of Obstetrics and Gynaecology Research

Volumn 41, Issue 11, 2015, Pages 1715-1720

  Seong, Won Joon ^a   Lee, Dong Young ^a   Koo, Tae Bon ^b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Andong Hospital   (South Korea)

Author keywords

CA 125; cervical length; matrix metalloproteinase 8; proinflammatory cytokines

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; NEUTROPHIL COLLAGENASE; TUMOR MARKER; TUMOR NECROSIS FACTOR;

ARTICLE; AUTOMATION; BLOOD LEVEL; CERVICAL LENGTH MEASUREMENT; CERVICAL SHORTENING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; OUTCOME ASSESSMENT; PREDICTION; PREGNANCY COMPLICATION; PROTEIN DETERMINATION; SECOND TRIMESTER PREGNANCY; UTERINE CERVIX MUCUS; ADULT; BLOOD; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RISK FACTOR; UTERINE CERVIX;

ADULT; BIOMARKERS; CA-125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CERVICAL LENGTH MEASUREMENT; CERVIX UTERI; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 8; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84946029823     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12782     Document Type: Article

References (34)

1. Andersen HF, Nugent CE, Wanty SD, Hayashi RH,. Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1990; 163: 859-867.
2. Williams M, Iams JD,. Cervical length measurement and cervical cerclage to prevent preterm birth. Clin Obstet Gynecol 2004; 47: 775-783.
3. Bischof P, What do we know about the origin of CA 125? Eur J Obstet Gynecol Reprod Biol 1993; 49: 93-98.
4. Gadler H, Wahren B, Lindsten J, Bremme K, Malmqvist E,. Carcinoembryonic antigen in amniotic fluid. Acta Med Scand 1977; 201: 411-413.
5. Barbati A, Anceschi MM, Alberti P, Pomili G, Di Renzo GC, Cosmi EV,. Ontogeny of CA 125 antigen in pregnancy: Immunoradiometric determination in amniotic fluid and immunohistochemical localization in fetal membranes. Am J Obstet Gynecol 1989; 160: 514-517.
6. Sarandakou A, Kontoravdis A, Kontogeorgi Z, Rizos D, Phocas I,. Expression of CEA, CA-125 and SCC antigen by biological fluids associated with pregnancy. Eur J Obstet Gynecol Reprod Biol 1992; 44: 215-220.
7. Sarandakou A, Protonotariou E, Rizos D,. Tumor markers in biological fluids associated with pregnancy. Crit Rev Clin Lab Sci 2007; 44: 151-178.
8. Kosar F, Aksoy Y, Ozguntekin G, Ozerol I, Varol E,. Relationship between cytokines and tumour markers in patients with chronic heart failure. Eur J Heart Fail 2006; 8: 270-274.
9. Sarandakou A, Phocas I, Botsis D, Rizos D, Trakakis E, Chryssikopoulos A,. Vaginal fluid and serum CEA, CA125 and SCC in normal conditions and in benign and malignant diseases of the genital tract. Acta Oncol 1997; 36: 755-759.
10. Williams MA, Hickok DE, Zingheim RW, Zebelman AM,. Maternal serum CA 125 levels in the diagnosis of abruptio placentae. Obstet Gynecol 1993; 82: 808-812.
11. Mazor M, Bashiri A, Ghezzi F, et al,. Maternal serum CA 125 is of prognostic value in patients with uterine bleeding in the detection of small-for-gestational-age neonates. Eur J Obstet Gynecol Reprod Biol 1996; 67: 143-147.
12. Suzuki Y, Yamamoto T, Kojima K, Tanemura M, Tateyama H, Suzumori K,. Evaluation levels of cytokines in amniotic fluid of women with intrauterine infection in the early second trimester. Fetal Diagn Ther 2006; 21: 45-50.
13. Figueroa R, Garry D, Elimian A, Patel K, Sehgal PB, Tejani N,. Evaluation of amniotic fluid cytokines in preterm labor and intact membranes. J Matern Fetal Neonatal Med 2005; 18: 241-247.
14. Saji F, Samejima Y, Kamiura S, Sawai K, Shimoya K, Kimura T,. Cytokine production in chorioamnionitis. J Reprod Immunol 2000; 47: 185-196.
15. Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ,. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model. Am J Obstet Gynecol 2006; 195: 1578-1589.
16. Tanaka Y, Narahara H, Takai N, Yoshimatsu J, Anai T, Miyakawa I,. Interleukin-1beta and interleukin-8 in cervicovaginal fluid during pregnancy. Am J Obstet Gynecol 1998; 179: 644-649.
17. Rizzo G, Capponi A, Vlachopoulou A, Angelini E, Grassi C, Romanini C,. The diagnostic value of interleukin-8 and fetal fibronectin concentrations in cervical secretions in patients with preterm labor and intact membranes. J Perinat Med 1997; 25: 461-468.
18. Törnblom SA, Klimaviciute A, Byström B, Chromek M, Brauner A, Ekman-Ordeberg G,. Non-infected preterm parturition is related to increased concentrations of IL-6, IL-8 and MCP-1 in human cervix. Reprod Biol Endocrinol 2005; 3: 39.
19. Nenadic DB, Pavlovic MD,. Cervical fluid cytokines in pregnant women: Relation to vaginal wet mount findings and polymorphonuclear leukocyte counts. Eur J Obstet Gynecol Reprod Biol 2008; 140: 165-170.
20. Hitti J, Hillier SL, Agnew KJ, Krohn MA, Reisner DP, Eschenbach DA,. Vaginal indicators of amniotic fluid infection in preterm labor. Obstet Gynecol 2001; 97: 211-219.
21. Sakai M, Sasaki Y, Yoneda S, et al,. Elevated interleukin-8 in cervical mucus as an indicator for treatment to prevent premature birth and preterm, pre-labor rupture of membranes: A prospective study. Am J Reprod Immunol 2004; 51: 220-225.
22. Holst RM, Jacobsson B, Hagberg H, Wennerholm UB,. Cervical length in women in preterm labor with intact membranes: Relationship to intra-amniotic inflammation/microbial invasion, cervical inflammation and preterm delivery. Ultrasound Obstet Gynecol 2006; 28: 768-774.
23. Jacobsson B, Mattsby-Baltzer I, Hagberg H,. Interleukin-6 and interleukin-8 in cervical and amniotic fluid: Relationship to microbial invasion of the chorioamniotic membranes. BJOG 2005; 112: 719-724.
24. González Bosquet E, Ferrer I, Valls C, Borrás M, Lailla JM,. The value of interleukin-8, interleukin-6 and interleukin-1beta in vaginal wash as predictors of preterm delivery. Gynecol Obstet Invest 2005; 59: 175-178.
25. Torbé A, Czajka R, Kordek A, Rzepka R, Kwiatkowski S, Rudnicki J,. Value of vaginal fluid proinflammatory cytokines for the prediction of early-onset neonatal infection in preterm premature rupture of the membranes. J Interferon Cytokine Res 2007; 27: 393-398.
26. Sakai M, Shiozaki A, Tabata M, et al,. Evaluation of effectiveness of prophylactic cerclage of a short cervix according to interleukin-8 in cervical mucus. Am J Obstet Gynecol 2006; 194: 14-19.
27. Kiefer DG, Keeler SM, Rust OA, Wayock CP, Vintzileos AM, Hanna N,. Is midtrimester short cervix a sign of intraamniotic inflammation? Am J Obstet Gynecol 2009; 200: 374.e1-374.e5.
28. Van Lint P, Libert C,. Matrix metalloproteinase-8: Cleavage can be decisive. Cytokine Growth Factor Rev 2006; 17: 217-223.
29. Maymon E, Romero R, Pacora P, et al,. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am J Obstet Gynecol 2000; 183: 94-99.
30. Nien JK, Yoon BH, Espinoza J, et al,. A rapid MMP-8 bedside test for the detection of intra-amniotic inflammation identifies patients at risk for imminent preterm delivery. Am J Obstet Gynecol 2006; 195: 1025-1030.
31. Kim KW, Romero R, Park HS, et al,. A rapid matrix metalloproteinase-8 bedside test for the detection of intraamniotic inflammation in women with preterm premature rupture of membranes. Am J Obstet Gynecol 2007; 197: 292.e1-292.e5.
32. Lee SJ, Won HS, Kim MN, Lee PR, Shim JY, Kim A,. Diagnostic value of the matrix metalloproteinase-8 rapid test for detecting microbial invasion of the amniotic cavity. Eur J Clin Microbiol Infect Dis 2008; 27: 1257-1260.
33. Rahkonen L, Rutanen EM, Unkila-Kallio L, et al,. Factors affecting matrix metalloproteinase-8 levels in the vaginal and cervical fluids in the first and second trimester of pregnancy. Hum Reprod 2009; 24: 2693-2702.
34. Diaz-Cueto L, Dominguez-Lopez P, Tena-Alavez G, Cuica-Flores A, Rosales-Ortiz S, Arechavaleta-Velasco F,. Effect of clindamycin treatment on vaginal inflammatory markers in pregnant women with bacterial vaginosis and a positive fetal fibronectin test. Int J Gynaecol Obstet 2009; 107: 143-146.